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Abstract 
Mozambique has historically been one of the countries with the highest malaria burden in the world. Starting in the 
1960s, malaria control efforts were intensified in the southern region of the country, especially in Maputo city and 
Maputo province, to aid regional initiatives aimed to eliminate malaria in South Africa and eSwatini. Despite signifi‑
cant reductions in malaria prevalence, elimination was never achieved. Following the World Health Organization’s 
renewed vision of a malaria‑free‑world, and considering the achievements from the past, the Mozambican National 
Malaria Control Programme (NMCP) embarked on the development and implementation of a strategic plan to accel‑
erate from malaria control to malaria elimination in southern Mozambique. An initial partnership, supported by the Bill 
and Melinda Gates Foundation and the La Caixa Foundation, led to the creation of the Mozambican Alliance Towards 
the Elimination of Malaria (MALTEM) and the Malaria Technical and Advisory Committee (MTAC) to promote national 
ownership and partner coordination to work towards the goal of malaria elimination in local and cross‑border initia‑
tives. Surveillance systems to generate epidemiological and entomological intelligence to inform the malaria control 
strategies were strengthened, and an impact and feasibility assessment of various interventions aimed to interrupt 
malaria transmission were conducted in Magude district (Maputo Province) through the “Magude Project”. The primary 
aim of this project was to generate evidence to inform malaria elimination strategies for southern Mozambique. The 
goal of malaria elimination in areas of low transmission intensity is now included in the national malaria strategic plan 
for 2017–22 and the NMCP and its partners have started to work towards this goal while evidence continues to be 
generated to move the national elimination agenda forward.
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Background
In 2014 the Mozambican National Malaria Control 
Programme (NMCP) and its partners started to work 
towards the global vision of a malaria-free world. This 
vision materialized in the NMCP’s strategic plan for 
2017–2022, which focuses on burden reduction in 
high endemic areas while sustaining the gains in low 
transmission areas to accelerate towards elimination. This 
article reviews the historical malaria control and elimina-
tion approach in Mozambique, and details the malaria 
elimination activities that the country has embarked on 
since 2014 in order to develop and implement a malaria 
elimination plan for southern Mozambique.
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The history of malaria control in Maputo Province, 
Southern Mozambique
Mozambique has been one of the countries with the 
highest malaria burden in Africa and in the world, 
according to available data [1–3]. However, the South-
ern region of Mozambique (Fig.  1), especially Maputo 
City and Province, has historically implemented activi-
ties aimed at reducing the burden of malaria in the area, 
and consequently lower the number of importations into 
its neighbouring countries—South Africa and eSwatini 
(former Swaziland) [4]. The first indoor residual spray-
ing (IRS) campaigns reported in southern Mozambique 
took place in 1946, using dichlorodiphenyltrichloroeth-
ane (DDT) and benzene hexachloride (BHC) [5, 6]. On 
the 27th of July of 1960, the World Health Organiza-
tion (WHO) and the Portuguese government approved 
a malaria elimination plan designed by the Brazilian 
malariologist Dr. Ferreira for the three provinces south 
of the Save river—Maputo, Gaza and Inhambane—with 
a population of approximately 1.5 million individuals [7, 
8]. This plan aimed to interrupt malaria transmission in 
the target areas and develop an elimination strategy with 
the neighbouring countries. To do so, a pilot project was 
implemented between 1960 and 1969 in the province of 
Maputo to test the feasibility to interrupt transmission 
in southern Mozambique through the use of IRS using 
DDT. The results from the pilot project indicated that 
malaria prevalence and vector density were significantly 
reduced to low and stable levels, and that ongoing trans-
mission was mainly driven by the importation of cases 
from areas outside the pilot zone, and by outdoor biting 
[8], but the transmission was not interrupted.
The civil war (1977–1992) led to the interruption of 
IRS in the 70s and 80s, which only resumed after the war 
ended. During the 90s, IRS with lambda-cyhalothrin and 
deltamethrin was only performed in selected suburban 
areas of the country [4]. In the early 2000s, the Lubombo 
Spatial Development Initiative (LSDI) was initiated 
between the governments of Mozambique, eSwatini and 
South Africa, with the objective of developing the agri-
culture industries and economies of these countries while 
also attempting to significantly reduce malaria incidence 
in the bordering areas with South Africa and eSwatini [9]. 
Through LSDI, yearly rounds of household IRS with ben-
diocarb were conducted, a surveillance system was estab-
lished, and availability of diagnostic and treatment was 
Fig. 1 Map of southern Mozambique and districts of Maputo Province—Magude district (in green) and all other districts of Maputo province (in 
orange)
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significantly enhanced between 2000 and 2011 in almost 
all districts of Maputo Province bordering eSwatini and 
South Africa (Table  1). The project failed to sustain 
the gains achieved, especially in Mozambique, due to 
financial constraints. However, the impact achieved on 
malaria incidence in South Africa and eSwatini led to the 
re-orientation of their respective malaria control pro-
grammes towards elimination [10].
A significant reduction of malaria burden—measured 
as malaria admissions, parasite and spleen rates in chil-
dren, or outpatient malaria incidence, depending on the 
year of evaluation—were reported after the implementa-
tion of the aforementioned IRS campaigns [4, 9]. How-
ever, it is worth noting that the evaluation of the impact 
on malaria incidence reported during LSDI may have 
been affected by the introduction in 2005 of the rapid 
diagnostic tests (RDTs) [11], which was a more specific 
diagnostic method than the previous one, based mostly 
on clinical symptoms. This, along with the introduction 
of a more efficacious first-line treatment (Table  1), may 
have significantly contributed to a decrease in the num-
ber of reported cases and deaths in the sprayed areas, 
considering that only approximately one third of chil-
dren with fever reporting to a health facility in the area 
or detected in the community were positive for malaria 
infection [12, 13].
Alongside these efforts, since 2000 the NMCP of 
Mozambique intensified its control strategy through 
the implementation of the core interventions recom-
mended by the World Health Organization (WHO) [14], 
i.e. efficacious anti-malarial drugs and vector control. 
Insecticide-treated nets (ITNs) began being distributed 
at the antenatal clinics and were also made available to 
children under 5 since the year 2000, and, in 2005, mass 
distribution of ITNs started in certain provinces of the 
country, aiming at 60% coverage of the most vulnerable 
populations, children aged less than 5  years and preg-
nant women. The country switched gradually from ITNs 
to long-lasting insecticide-treated nets (LLINs) start-
ing in 2006. Since 2014, universal distribution of LLINs 
(one for every two individuals) has been conducted every 
3rd year.
Around 2003, with the advent of the Global Fund to 
fight AIDS, Tuberculosis, and Malaria (GFATM), the 
NMCP reintroduced IRS with pyrethroids in selected 
districts across the country. In 2005, the MoH reintro-
duced DDT and expanded IRS implementation to over 
40 districts countrywide through 2009, and to 62 districts 
between 2010 and 2015 [15].
Different artemisinin-based combinations have been 
used as a first-line treatment since 2002 in response to 
the growing resistance to chloroquine, and intermittent 
preventive treatment for pregnant women (IPTp) with 
sulfadoxine–pyrimethamine was introduced in 2005 at 
the antenatal clinics (Table 1). These interventions are 
funded by the Mozambican government with support 
Table 1 Main malaria control interventions deployed in Maputo Province since 1946 until 2014
a Universal distribution of LLINS: one LLIN for every two people in the household
Year Area Intervention Source
1946–56 Semi‑urban area of Maputo city and rural areas of the 
Limpopo Valley
IRS (DDT and BHC) [5–7]
1960–69 Maputo Province IRS (DDT) [4]
1993 Suburban areas of most provincial capitals IRS (deltamethrin and lambda‑cyhalothrin)
2000 IRS in Maputo province 2000–2011: “LSDI” IRS (bendiocarb) in all districts of Maputo 
province except Manhiça
2011–2017: District‑level or targeted IRS in some districts of 
Maputo province
2017–2019: Province‑level IRS through MOSASWA
[9, 10]
2003 Selected districts IRS (with DDT, pyrethroids or bendiocarb) [11, 39]
2005 Country‑level Introduction of RDTs
2000 Country‑level ITNs for pregnant women and children under 5
2005–2014 Provincial‑level Mass ITN distributions
2017 Country‑level Universal distribution of  LLINsa
2005 Country‑level IPTp at ANC with SP
2002–2004 Country‑level Introduction of AQ + SP as first line treatment
2004–2009 Country‑level First‑line treatment changed to AS + SP
2009–2011 Country‑level First‑line treatment changed to AL
2011 Country‑level AQ + AS added as an alternative first‑line treatment to AL 
for non‑complicated malaria
AS or parenteral QNN adopted for severe malaria treatment
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mainly from the GFATM and the United States Presi-
dent’s Malaria Initiative (PMI), the latter since 2007 
[11, 15].
The prevalence of malaria in children of Maputo 
Province has declined from > 60% before the year 2000, 
to < 30% by 2005, to < 3% in 2015 [9, 16–18] (Fig.  2). 
This reduction is probably multifactorial, associated 
with the significant socioeconomic changes that took 
place in the country during the last decades (expan-
sion of urbanization, changes in land use, increased 
education, increased per capita GDP, etc.), as well as 
a result of the malaria control efforts, including LSDI, 
despite the relatively low coverage of IRS (< 50%) and 
ITNs (< 30%) estimated for Maputo province through 
national surveys conducted in 2007 [16], 2011 [17] and 
2015 [18]. This reduction was not homogeneous within 
Maputo Province, as high incidence rates (> 200 cases 
per 1000 per year) were still observed in the district 
of Manhiça between 2000 and 2013 [19, 20]. The het-
erogeneity of transmission is also mirrored at coun-
try level, where estimates of Plasmodium falciparum 
malaria prevalence ranged from 16% in Gaza province 
(north of Maputo) to 67.6% in the northern province of 
Zambezia [18], and the WHO estimated that approxi-
mately 9.5 million cases and 16,000 deaths were due to 
malaria in 2015 [3].
The rationale for malaria elimination in southern 
Mozambique
While the last decade had witnessed significant reduc-
tions in the burden of malaria throughout the country, 
the gains have since stalled, and an increase in disease 
incidence consistent with modelled estimates [21, 22] has 
been reported since 2014 throughout the country [23]. 
In this context, it was clear that business as usual was no 
longer an option for Mozambique, and the country had 
no option but to intensify its control efforts to meet the 
targeted decrease in malaria incidence and mortality in 
the national strategic plan [11]. The NMCP of Mozam-
bique followed the recommendations established by the 
WHO of increasing the coverage of all core interventions 
(vector control, case management, and case surveillance) 
throughout the country, while simultaneously developing 
and implementing a strategic plan to accelerate to elimi-
nation in the south, where malaria burden was the lowest 
[24].
While recognizing that malaria elimination in Mozam-
bique is extremely ambitious, there were multiple reasons 
that encouraged the country to embark on an elimina-
tion effort in the south in 2014. First, there was a need to 
demonstrate the feasibility and impact of malaria elimi-
nation to inform the design of new elimination strate-
gies in endemic countries where scale-up of control is 
still challenging, and the question remains as to whether 
elimination is really feasible and biologically plausible 
[22, 25, 26]. Multiple research efforts were already under-
way across varying geopolitical and transmission zones 
to inform global policies for elimination, the major-
ity in countries with low to moderate transmission lev-
els nationally, such as South Africa, eSwatini [10] and 
Namibia [27], or with strong health systems, as countries 
in the Asia–Pacific region [28]. Mozambique, as well as 
Zambia, where intensive malaria control projects were 
already ongoing [29], provided an optimal environment 
to evaluate whether interventions aiming to interrupt 
malaria transmission could be implemented, and elimina-
tion achieved and sustained cost-effectively. Proving that 
malaria elimination could be achieved in these countries 
would provide a convincing advocacy and mobilization 
argument for aiming for elimination in Africa. It would 
additionally offer a good counter-argument to the dis-
couraging predictions of future malaria increases world-
wide if no acceleration efforts were put in place [21, 30].
Second, the opportunity for regional impact was 
higher than ever. Surveillance data from eSwatini and 
South Africa reportedly identified imported cases from 
Mozambique as one of the main challenges preventing 
them from completely interrupting transmission. As a 
result, there was a growing recognition that successful 
elimination in South Africa and eSwatini would require a 
cross-border approach that aggressively targets southern 
Mozambique, the major source of malaria importation in 
the region [10].
Finally, an unprecedented enthusiasm and support 
from local and global partners and funding institutions 
arose to define and implement a malaria elimination 
strategy for the south of Mozambique. This enthusi-
asm needed to be channelled through the creation of a 
coordination mechanism that would facilitate partner 
Fig. 2 Historical malaria prevalence in children reported between 
1999–2005 for 2–15 year olds (Sharp et al. [9]), and in 2007 (MIS 
[16]), 2011 (DHS [17]) and 2015 (MIS [18]) for < 5 year olds in Maputo 
Province, Southern Mozambique
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collaboration and provide a structure through which 
the NMCP could lead all partners under a single plan. It 
would also serve to identify the human resources, man-
agement infrastructure and health systems gaps required 
to embark on a malaria elimination mission led nationally 
as recommended by WHO [31].
Setting the scene for malaria elimination 
in Southern Mozambique
Responding to the growing needs to address all aspects 
that positioned southern Mozambique in the path of 
malaria elimination, in 2014 the La Caixa Foundation 
(LCF) and the Bill & Melinda Gates Foundation (BMGF) 
jointly funded a grant to the Barcelona Institute for 
Global Health (ISGlobal) and the Centro de Investigação 
em Saúde de Manhiça (CISM) to design and implement, 
in collaboration with the Mozambican NMCP, a 5-year 
malaria elimination programme with the overall goal of 
designing, implementing and evaluating a malaria elimi-
nation strategy for southern Mozambique. Around this 
time, the Elimination 8 Initiative and the Mozambique, 
South Africa and eSwatini (MOSASWA) regional ini-
tiative were created through GFATM funding, with the 
main objective of significantly reducing malaria sub-
nationally in Southern Mozambique in order to achieve 
the malaria elimination target in South Africa and 
eSwatini by 2020 [32].
The 5-year malaria elimination program that resulted 
from the LCF and the BMGF partnership, spearheaded 
the introduction of the malaria elimination strategy into 
the country’s agenda. The program aimed to learn from 
the previous malaria elimination attempts in Africa by 
adopting a horizontal approach that focused on (i) pro-
moting national ownership and partner coordination to 
work towards the goal of malaria elimination in local and 
regional initiatives, (ii) generating epidemiological and 
entomological intelligence through strengthened sur-
veillance systems to inform the deployment of malaria 
control strategies and evaluate their impact; and (iii) 
evaluating the impact and feasibility of interventions 
aimed to interrupt malaria transmission through a dem-
onstration project of malaria elimination in Magude, a 
district of Maputo Province.
The creation of a national alliance for malaria 
elimination
Acknowledging the importance of national ownership 
for the success of any public health activity, the malaria 
elimination programme placed substantial efforts on the 
creation of a national platform to support the NMCP to 
design, fund and implement a national malaria elimi-
nation plan for the south. As a result, the Mozambican 
Alliance Towards the Elimination of Malaria (MALTEM) 
or “Aliança pela Eliminação de Malária em Moçam-
bique” (ALEMMO) in Portuguese, was created as a 
collaboration between independent institutions work-
ing on malaria in Mozambique. Chaired by the NMCP, 
MALTEM was launched in July 2015 and included mem-
bers from various sectors: Multilateral Agencies (WHO, 
Roll Back Malaria Partnership, United Nations Children’s 
Fund (UNICEF) and GFATM); bilateral agencies (PMI 
and United States Agency for International Development 
(USAID)); academic and research centres (CISM and 
ISGlobal); and private foundations (Good Bye Malaria 
(GBM), Fundação para o Desenvolvimento da Comuni-
dade (FDC), BMGF, LCF, the Clinton Health Access Ini-
tiative (CHAI), Malaria Consortium and World Vision).
MALTEM’s main objectives stated in its Terms of 
Reference were to “create the necessary knowledge to 
inform an operational elimination plan and roadmap 
for malaria elimination in Mozambique; ensure that the 
NMCP has the necessary capacities to implement inno-
vative strategies to improve control of malaria and inter-
rupt transmission; align efforts for political engagement 
and raise further resources of funding including domestic 
ones; and identify synergies to ensure that potential over-
laps or duplicated efforts are avoided and that the best 
uses of resources are guaranteed.” In-country members of 
MALTEM met regularly upon NMCP’s request and once 
a year with the MoH and its funders (BMGF and LCF).
An Advisory Committee for MALTEM (MAC) includ-
ing malaria elimination experts and NMCP managers 
from Africa was constituted to provide independent 
scientific and strategic advice to MALTEM and support 
the evidence generation process to achieve malaria elimi-
nation in Southern Mozambique. MAC members met 
on an annual basis between 2015 and 2018. Finally, an 
independent national Malaria Technical Advisory Com-
mittee (MTAC) was created under a ministerial decree, 
to provide technical and scientific advice to the MoH to 
develop evidence-based policies for the control and even-
tual elimination of malaria in the country. This body con-
tributed to provide a consensual and stable environment 
and robust leadership to strengthen the malaria control 
activities in Mozambique inspired on the successful 
model of the WHO Malaria Policy Advisory Committee 
(MPAC).
As a result of the creation of these platforms, the 
2017–2022 National Strategic Plan of the Mozambican 
NMCP included the goal of malaria elimination and cre-
ated a specific Technical Working Group (TWG), open-
ing the doors to the development and implementation of 
a detailed subnational elimination plan for the southern, 
lowest endemic districts. An evaluation was conducted 
early in 2015 to identify the human resource needed to 
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strengthen the central NMCP in order to respond to the 
demands posed by the elimination agenda. This analysis 
revealed that while most NMCP positions were already 
filled, the existing NMCP personnel lacked necessary 
core capabilities and competencies, including pro-
gramme management, concept development, analytical 
skills and strategic planning, coaching and training skills. 
In addition to sharing the findings of this assessment 
with key NMCP stakeholders, three technical staff were 
hired by MALTEM and seconded to the NMCP to fill 
the most relevant gaps identified at the time, namely, one 
vector control officer at central level, one entomological 
assistant at provincial level (for Maputo province) and 
one surveillance officer at district level in Magude.
Moreover, in order to address some of the gaps identi-
fied in terms of core competencies and capabilities of the 
NMCP personnel, several MALTEM members organized 
short courses tailored to individuals at national, provin-
cial, district and community level between 2015 and 2018 
on a variety of topics relevant to malaria control and 
elimination. These courses included malaria surveillance 
and entomological training (by CISM and ISGlobal), 
as well as a variety of community-level training on IRS 
deployment (by Good Bye Malaria), community engage-
ment (by CISM and FDC), and mass or focal drug admin-
istration (MDA) activities (by CISM and ISGlobal). Every 
year, since 2016, CISM and ISGlobal supported the par-
ticipation of NMCP personnel at the Science of Eradica-
tion courses, organized by the Universities of Barcelona, 
Harvard, and Basel. Additionally, a large group of young 
Mozambicans was hired to take part in the research 
activities at CISM to acquire programme implementation 
and operational research experience, with the vision that 
they would maintain and expand the in-country expertise 
on malaria surveillance, epidemiology and entomology.
Several advocacy events were organized involving 
various Mozambican leaders at all levels. These included 
briefings with community leaders, district/province 
health and administrative leaders, as well as the Minister 
of Health. These meetings aimed to socialize the idea of 
elimination and establish an inclusive decision-making 
process to ensure national ownership at all levels. The 
advocacy effort was also aimed at raising domestic finan-
cial commitments both from the private sector as well as 
from the government. While political commitment was 
achieved at all levels, leveraging national resources for 
malaria elimination was challenged by the massive finan-
cial crisis that the country is experiencing since 2015.
Strengthening epidemiological and entomological 
surveillance systems
In 2015, the Mozambique Health Information Sys-
tem changed the procedures for collecting malaria data 
from the district to the national level, from a paper-
based system to an electronic system using the District 
Health Information System 2 (DHIS2) platform to obtain 
monthly malaria indicators from all districts in the coun-
try, with support from the GFATM. Aggregate malaria 
data are reported by age group (below and above 5 years 
of age), including total outpatient visits, RDTs and/or 
microscopy performed, positive RDTs/microscopy, sus-
pected malaria cases (if not tested for any reason but 
assumed to be malaria according to symptoms) and treat-
ment provided (ACT). However, data from health facili-
ties (HF) and community health workers (CHW) are still 
collected on paper and sent to the district to be entered 
electronically into DHIS2. Since 2015, the malaria elimi-
nation programme further expanded the DHIS2 sys-
tem to obtain monthly electronic data from all HFs and 
CHWs in four of the eight districts of Maputo Province, 
namely Marracuene, Moamba, Manhiça, and Magude; 
while also establishing a rapid reporting system for 
weekly data collection in the district of Magude. Quar-
terly data quality audits were gradually established in the 
4 districts to evaluate the timeliness, completeness, and 
accuracy of the data collected.
An entomological surveillance platform was estab-
lished at six sentinel sites in Magude district in 2015 and 
in one additional sentinel site in Xinavane town in 2016 
to (i) better tailor vector control strategies to the entomo-
logical context of the area and (ii) assess the effectiveness 
of vector control interventions. Vector species composi-
tion, mosquito densities and infection rates were moni-
tored in/around Magude town, and insecticide resistance 
was monitored annually to inform the selection of IRS 
insecticides. Monthly residual efficacy of IRS was also 
monitored.
Based on lessons learned, entomological surveillance 
activities were redesigned in 2018 and new entomologi-
cal surveillance techniques were implemented, such as 
human-baited tent traps placed both indoors and out-
doors, early-morning pyrethrum spray catches, and win-
dow exit traps. Activities were also expanded to Gaza and 
Inhambane provinces in order to collect essential, timely 
and quality entomological information to monitor the 
vector population and inform the IRS strategy planned 
for Gaza and Inhambane under the MOSASWA regional 
initiative.
The “Magude” project: assessing the feasibility of malaria 
elimination
Despite the successes in controlling the disease in 
sub-Saharan Africa, the region still houses the coun-
tries with the highest malaria burden in the world [33]. 
Interrupting malaria transmission and, ultimately, 
eliminating the parasite from this region is a long-term 
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goal that will require innovation through research and 
deployment of elimination strategies specifically tai-
lored to high burden areas [34]. This was precisely 
the goal of the Garki Project, undertaken in Northern 
Nigeria in the context of the Global Malaria Eradication 
Program (GMEP) between 1969 and 1976, to assess the 
feasibility of interrupting transmission in the African 
savanna with the tools available at the time. This pro-
ject compared 7 rounds of IRS with propoxur, to the 
same IRS approach in combination with 9 or 23 rounds 
of MDA using sulfalene-pyrimethamine throughout 
a 2-year period. The main conclusion from the Garki 
project was that malaria burden had been significantly 
reduced through these strategies, but elimination 
was not achieved during the established intervention 
period with the interventions deployed, and malaria 
rebounded after its discontinuation [35].
The results have often been interpreted as a confir-
mation that the goal was at that point unachievable. 
However, today, newly available tools, together with 
innovative strategies, may facilitate achievement of 
malaria elimination in the low transmission areas of 
Africa [14]. In line with the renewed interest in malaria 
elimination in southern Mozambique, a malaria elimina-
tion project called the “Magude project” was designed by 
ISGlobal, CISM and the NMCP to revisit the feasibility of 
malaria elimination in endemic countries of Africa with 
the currently available tools and technologies.
The district of Magude (Maputo province, southern 
Mozambique) was selected as the area where the feasi-
bility of malaria elimination would be evaluated based 
on a series of district characteristics that would pose the 
type of challenges expected to be faced by the NMCP 
while implementing a malaria elimination campaign 
country-wide. This district was included in the baseline 
malaria surveys conducted in preparation for the 1960s 
elimination plan, which revealed a 44% prevalence of 
infection by microscopy in 1958 [7]. It also received the 
LSDI activities (Zone 3), during which the prevalence 
by RDT dropped from 77% in 2003 to 33% in 2005 [9] 
and to < 10% between 2008 and 2011 [36]. The number 
of cases reported per year from Magude after the end of 
LSDI increased from 9845 in 2012 to 13,661 in 2014 (38% 
increase). However, this increasing trend was generally 
observed throughout the country, but no comparisons 
could be made with regards to incidence trends during 
the LSDI due to the inaccuracy of the national routine 
surveillance data [3, 36].
The aim of the Magude project was to assess the feasi-
bility and impact of a comprehensive malaria elimination 
package that combined routine malaria control activi-
ties with innovative interventions to interrupt trans-
mission. The package of interventions consisted of: (i) 
standard of care using HRP2-based RDTs for diagnosis 
and artemether–lumefantrine for treatment, delivered 
by the MoH in the district; (ii) enhanced entomological 
and epidemiological intelligence through an improved 
surveillance and reporting system; (iii) a strong com-
munity engagement campaign to maximize acceptance 
and coverage of interventions; (iv) universal coverage 
of IRS with DDT and/or Actellic 300 CS (pirimiphos-
methyl) performed at the end of the dry season on top 
of the LLINs distributed by the NMCP in 2014 and 2017; 
and (iv) two population-wide Mass Drug Administration 
(MDA) rounds with dihydroartemisinin–piperaquine 
(DHAp) per year for two consecutive years followed by 
reactive focal Mass Drug Administration (rfMDA) of 
contacts of passively detected cases. Several research 
studies also took place simultaneously in order to assess 
the clinical and socio-demographic profile of cases with 
malaria infection through time; the community’s adher-
ence and acceptability to the interventions; DHAp 
safety and resistance; HRP2 deletions; LLIN integrity 
and bio-efficacy, the sleeping behaviours in the com-
munity in relation to LLIN use; the cost-effectiveness of 
the interventions, and their impact on school and work 
absenteeism.
The rationale was that a combination of vector control 
and population-wide anti-malarial drug interventions 
would lead to a significant reduction in the mosquito 
population, as well as in the human parasite reservoir. In 
the context of a diminished vector population, the long 
prophylactic effect of repeated anti-malarial drug doses 
would protect individuals from pre-treatment infected 
mosquitoes, while the new generation of mosquitoes 
would feed onto post-treatment non-infected humans 
thus leading to the interruption of the malaria transmis-
sion cycle.
The project was divided into three phases presented in 
Fig. 3 in detail:
1. Preparatory phase (September 2014 to August 2015) 
a census and a malaria infection prevalence survey 
were conducted to obtain community baseline data. 
Epidemiological and entomological surveillance sys-
tems were established. During this phase, two stud-
ies were performed in the neighbouring district of 
Manhiça to evaluate the efficacy of chloroquine and 
the prevalence of G6PD deficiency for the use of 
primaquine, to inform about their potential use in 
future elimination interventions [37, 38].
2. Phase I (August 2015 to June 2017) implementa-
tion of the first set of interventions aiming at inter-
rupting transmission. One round of IRS followed by 
two rounds of MDA were implemented during two 
consecutive rainy seasons. A community engage-
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ment campaign was also conducted to increase the 
use of LLINs and maximize acceptance of IRS and 
MDA. The census was updated in 2016 and two more 
malaria infection prevalence surveys were conducted 
at the end of each transmission season (May 2016 
and May 2017).
3. Phase II and transition to programmatic mode (July 
2017 to September 2019) implementation of a second 
set of interventions aiming at sustaining the gains 
achieved during phase I through the deployment of 
three more annual rounds of IRS at the end of the dry 
season of 2017, 2018 and 2019, coupled with rfMDA 
established in July 2017; a universal LLIN distribu-
tion conducted by the NMCP in December of 2017; 
two parasite surveys in May of 2018 and 2019; and 
another census update at the end of 2018.
Lessons learned
Several lessons were learnt from the implementation of 
the malaria elimination programme. Bringing several 
NMCP stakeholders together to form MALTEM was 
not an easy undertaking for several reasons. First, there 
was a strong scepticism about the feasibility of elimina-
tion in such a high malaria burden country; second, most 
stakeholders’ institutions had not formally endorsed the 
elimination agenda; third, the priority for the NMCP and 
its partners were the high burden regions of the country, 
particularly northern Mozambique. These constraints 
hampered the functioning of MALTEM, limiting its 
efficiency. On the other hand, other drivers were key in 
fuelling the alliance, particularly WHO’s headquarters’ 
strong leadership, through the endorsement of the global 
technical strategy by the 2015 World Health Assembly 
and BMGF’s leadership, especially in the field of evidence 
generation across the globe.
A key lesson learned from MALTEM’s advocacy pro-
cess is that advocacy for elimination has to begin by 
targeting the country’s leadership at its highest level, in 
order to elicit not only their political support but also a 
financial commitment from domestic funding.
The introduction of malaria elimination in the NMCP’s 
agenda was another challenge, not only for the reasons 
listed above but most importantly due to the risk of polit-
ical fallout that could arise from prioritizing elimination 
activities in one region over other competing needs. To 
overcome this, rather than focusing on elimination in 
the south, the NMCP strategy presented a more dynamic 
approach that would be guided by local epidemiological 
contexts. Another key factor that facilitated the adop-
tion of the elimination agenda was the country’s regional 
commitment with its southern neighbours in the con-
text of MOSASWA and E8. While the NMCP eventually 
embraced the elimination agenda and included it in its 
strategic plan, the NMCP’s investments priorities natu-
rally remained in northern Mozambique, subjecting the 
implementation of elimination-oriented activities to the 
availability of specific additional funding.
In terms of strengthening the surveillance system the 
authors had initially thought of a hybrid approach; on 
one hand, to support the DHIS2 surveillance platform 
implementation in the district, led by the MoH; whereas, 
Fig. 3 Design of the Magude Project including the interventions implemented (green, “x”), the activities for the collection of primary data to 
evaluate the impact of the interventions (yellow, “+”), and the research activities performed during the project (blue, “o”) between 2014 and 2019
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on the other hand, to invest in a parallel surveillance sys-
tem, building on the long-term experience of running a 
round-the-clock facility-based passive case detection at 
Manhiça district hospital. The latter, however, proved to 
be a colossal task given the level of investment that would 
need to be made in terms of personnel, having prevailed 
the former. This, however, came with its own human, 
logistical and technological challenges that had to be 
overcome through direct provision of technical, logistical 
and technological support. In order to minimize the risk 
of disruption of the surveillance after the end of the pro-
ject, no changes were made to the reporting tools and the 
paper-based reporting system remained as a backup sys-
tem throughout the project. Moreover, the project team 
worked tirelessly to attract new funding to continue sup-
porting surveillance while continuing to advocate for its 
full absorption by the health system itself.
The key lessons from this experience in Magude in 
relation to surveillance were that any similar initiative 
should avoid trying to setup parallel systems as these can 
be costly and not sustainable in the long run. Also, while, 
technical support is important, it is equally important to 
plan for some level of logistic support while continuously 
advocating for the health system to fully absorb the sur-
veillance needs.
Overall, the Magude project faced several challenges 
inherent to the implementation of MDA in a research 
context, using a relatively new drug for which there was 
still limited safety data especially in individuals without 
the disease. To overcome this, high-level advocacy had 
to be undertaken at all levels, from central, provincial 
to district level prior to the community mobilization. In 
addition, formative research in social science was under-
taken before, during and after the MDAs to continuously 
inform the deployment of the MDA intervention and 
adapt it according to the learnings being acquired.
Concluding remarks
Southern Mozambique has experienced several malaria 
elimination attempts during the twentieth century, 
which together with the NMCP’s efforts to control 
the disease nationally and the socio-economic devel-
opment, have led to a significant reduction of malaria 
prevalence in the area. In 2014, a partnership between 
the La Caixa Foundation and the Bill and Melinda Gates 
Foundation prompted the creation of a malaria elimina-
tion programme in southern Mozambique that aimed 
to pave the way for malaria elimination in the country 
through the establishment of nationally-led platforms 
to design a plan for the south, based on the evidence 
generated through a malaria elimination demonstra-
tion project in the district of Magude. The Mozam-
bican Alliance Towards the Elimination of Malaria 
(MALTEM) and the Malaria Technical Advisory Com-
mittee (MTAC) were created to strengthen partner 
communication, facilitate the adoption of evidence-
based policies and secure funding for malaria elimi-
nation. As a result, the goal of malaria elimination in 
areas of low transmission intensity was included in the 
national malaria strategic plan for 2017–22 and several 
partners of the NMCP have started to work towards 
this goal. Additionally, the partnership led to the 
design, implementation and evaluation of the Magude 
Project, for the generation of in-country evidence on 
the feasibility and affordability of malaria elimination 
in the south to guide policymaking. The implementa-
tion of all these activities has offered key lessons that 
should be considered in any future malaria elimination 
endeavours in Mozambique, which might also be appli-
cable in other countries aiming for elimination. Overall, 
since 2014, the Mozambican NMCP has significantly 
strengthened its approach to malaria policy-making, 
with a focus on elimination, through the creation of 
coordination mechanisms that offer their technical and 
financial support, as well as through the generation of 
in-country evidence to guide malaria elimination strat-
egies in Mozambique.
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